Assessing the clinical utility of cancer genomic and proteomic data across tumor types
出版年份 2014 全文链接
标题
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume 32, Issue 7, Pages 644-652
出版商
Springer Nature
发表日期
2014-06-23
DOI
10.1038/nbt.2940
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
- (2014) N. Wagle et al. Cancer Discovery
- miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
- (2013) H.W.Z. Khella et al. CARCINOGENESIS
- Characteristics of Lung Cancers Harboring NRAS Mutations
- (2013) K. Ohashi et al. CLINICAL CANCER RESEARCH
- Clinical Analysis and Interpretation of Cancer Genome Data
- (2013) Eliezer M. Van Allen et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomics-Driven Oncology: Framework for an Emerging Paradigm
- (2013) Levi A. Garraway JOURNAL OF CLINICAL ONCOLOGY
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Systematic Analysis of Challenge-Driven Improvements in Molecular Prognostic Models for Breast Cancer
- (2013) A. A. Margolin et al. Science Translational Medicine
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
- (2013) N. Wagle et al. Cancer Discovery
- The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
- (2013) E. M. Van Allen et al. Cancer Discovery
- Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling
- (2013) Erhan Bilal et al. PLoS Computational Biology
- The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells
- (2012) Toshihiko Sakurai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Predicting the lethal phenotype of the knockout mouse by integrating comprehensive genomic data
- (2012) Yuan Yuan et al. BIOINFORMATICS
- MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma
- (2012) Yang Ni et al. GENE
- Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
- (2012) Lisa M. McShane et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With MetastaticBRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor
- (2012) Kevin B. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma
- (2012) Hala Faragalla et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Use of personalized molecular biomarkers in the clinical care of adults with glioblastomas
- (2012) Matthias Holdhoff et al. JOURNAL OF NEURO-ONCOLOGY
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
- (2012) Pasi A Jänne et al. LANCET ONCOLOGY
- Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
- (2012) Mohd Saif Zaman et al. PLoS One
- Genome Sequencing Identifies a Basis for Everolimus Sensitivity
- (2012) G. Iyer et al. SCIENCE
- Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
- (2012) James W. Antoon et al. Scientific Reports
- Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc
- (2011) Yongchao Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells
- (2011) Syunsuke Noguchi et al. CANCER LETTERS
- A microRNA survival signature (MiSS) for advanced ovarian cancer
- (2011) Karin K. Shih et al. GYNECOLOGIC ONCOLOGY
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer
- (2011) Shuli Liang et al. PLoS One
- High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
- (2011) Nikhil Wagle et al. Cancer Discovery
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Current and emerging biomarkers in breast cancer: prognosis and prediction
- (2010) Marion T Weigel et al. ENDOCRINE-RELATED CANCER
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
- (2010) NATURE BIOTECHNOLOGY
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
- (2009) Laura E. MacConaill et al. PLoS One
- Random survival forests
- (2008) Hemant Ishwaran et al. Annals of Applied Statistics
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started